The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Recent advances in the pharmacological diversification of quinazoline/quinazolinone hybrids
Open accessAbstract
Recent advances in quinazoline/quinazolinone hybrid heterocycles in medicinal chemistry and their pharmacological diversification.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug Discovery: A Historical Perspective
Drews, J. (2000) · Science · doi:10.1126/science.287.5460.1960 · Cited by 2,760
Diabetes and Cancer: A Consensus Report
Giovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., Pollak, M., Regensteiner, J. G., & Yee, D. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20078 · Cited by 1,055
Regulation of angiogenesis via vascular endothelial growth factor receptors.
Veikkola, T., Karkkainen, M. J., Claesson, L., & Alitalo, K. K. (2000) · PubMed · Cited by 864
A Specific Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase
Fry, D. W., Kraker, A. J., McMichael, A., Ambroso, L. A., Nelson, J. M., Leopold, W. R., Connors, R. W., & Bridges, A. J. (1994) · Science · doi:10.1126/science.8066447 · Cited by 806
Genin, M. J., Allwine, D. A., Anderson, D. J., Barbachyn, M. R., Emmert, D. E., Garmon, S. A., Graber, D. R., Grega, K. C., Hester, J. B., Hutchinson, D. K., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990373e · Cited by 729
Recent Researches in Triazole Compounds as Medicinal Drugs
-H. Zhou, C., & Wang, Y. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712803414213 · Cited by 636
Mok, T. S., Cheng, Y., Zhou, X., Lee, K. H., Nakagawa, K., Niho, S., Lee, M., Linke, R., Rosell, R., Corral, J., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.78.7994 · Cited by 439
Molecular Hybridization as a Tool for Designing Multitarget Drug Candidates for Complex Diseases
Ivasiv, V., Albertini, C., Gonçalves, A. E., Rossi, M., & Bolognesi, M. L. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666190619115735 · Cited by 375
Synthesis and antifungal activity of 1,2,3-triazole containing fluconazole analogues
Aher, N. G., Pore, V. S., Mishra, N. N., Kumar, A., Shukla, P. K., Sharma, A., & Bhat, M. K. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.12.026 · Cited by 328
Coumarin hybrids as novel therapeutic agents
Sandhu, S., Bansal, Y., Silakari, O., & Bansal, G. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.05.032 · Cited by 296
Recent advances (2015–2016) in anticancer hybrids
Kerru, N., Singh, P., Koorbanally, N., Raj, R., & Kumar, V. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.07.033 · Cited by 295
Khan, I., Zaib, S., Batool, S., Abbas, N., Ashraf, Z., Iqbal, J., & Saeed, A. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.03.031 · Cited by 280
Carbonic anhydrase inhibitors: Sulfonamides as antitumor agents?
Supuran, C. T., Briganti, F., Tilli, S., Chegwidden, W. R., & Scozzafava, A. (2001) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(00)00288-1 · Cited by 277
Abbate, F., Casini, A., Owa, T., Scozzafava, A., & Supuran, C. T. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.09.062 · Cited by 262
Hameed, A., Al-Rashida, M., Uroos, M., Ali, S. A., Arshia, Ishtiaq, M., & Khan, K. M. (2018) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2018.1432596 · Cited by 258
Al-Zoman, N. Z., Maher, H. M., & Al-Subaie, A. (2017) · Chemistry Central Journal · doi:10.1186/s13065-016-0232-6 · Cited by 242
Chandrika, P. M., Yakaiah, T., Rao, A. R. R., Narsaiah, B., Reddy, N. C., Sridhar, V., & Rao, J. V. (2008) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2007.06.010 · Cited by 232
Multitarget Drug Discovery and Polypharmacology
Bolognesi, M. L., & Cavalli, A. (2016) · ChemMedChem · doi:10.1002/cmdc.201600161 · Cited by 231
Vascular Endothelial Cell Growth Factor (VEGF), An Emerging Target for Cancer Chemotherapy
Shinkaruk, S., Bayle, M., Lain, G., & Deleris, G. (2003) · Current Medicinal Chemistry-Anti-Cancer Agents · doi:10.2174/1568011033353452 · Cited by 219
Zoumpoulakis, P., Camoutsis, C., Pairas, G., Soković, M., Glamočlija, J., Potamitis, C., & Pitsas, A. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.12.031 · Cited by 200
Al-Rashood, S. T., Aboldahab, I. A., Nagi, M. N., Abouzeid, L. A., Abdel-Aziz, A. A. M., Abdel-hamide, S. G., Youssef, K. M., Al-Obaid, A. M., & El-Subbagh, H. I. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.08.030 · Cited by 191
Gawad, N. M. A., Georgey, H. H., Youssef, R. M., & El‐Sayed, N. A. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.10.008 · Cited by 172
Decker, M. W. (2005) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2004.12.003 · Cited by 166
Simoni, D., Grisolia, G., Giannini, G., Roberti, M., Rondanin, R., Piccagli, L., Baruchello, R., Rossi, M., Romagnoli, R., Invidiata, F. P., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049622b · Cited by 149
Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIF
Pullamsetti, S. S., Banat, G. A., Schmall, A., Szibor, M., Pomagruk, D., Hänze, J., Kołosionek, E., Wilhelm, J., Braun, T. W., Grimminger, F., et al. (2012) · Oncogene · doi:10.1038/onc.2012.136 · Cited by 143
Antitumor 2,3-dihydro-2-(aryl)-4(1H)-quinazolinone derivatives
Hamel, E., Lin, C. M., Plowman, J., Wang, H., Lee, K.-H., & Paull, K. D. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)02156-6 · Cited by 139
Kümmerle, A. E., Schmitt, M., Cardozo, S. V. S., Lugnier, C., Villa, P., Lopes, A. B., Romeiro, N. C., Justiniano, H., Martins, M. A., Fraga, C. A. M., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300514y · Cited by 123
Synthesis and biological activity of novel antibacterial quinazolines
Bedi, P. M. S., Kumar, V., & Mahajan, M. P. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.07.065 · Cited by 123
Wang, Y., Damu, G. L. V., Lv, J.-S., Geng, R., Yang, D., & Zhou, C. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.07.064 · Cited by 119
A Phase I/Ib Trial of the VEGFR-Sparing Multikinase RET Inhibitor RXDX-105
Drilon, A. E. D. C., Fu, S., Patel, M. R., Fakih, M., Wang, D., Olszanski, A. J., Morgensztern, D., Liu, S. V., Cho, B. C., Bazhenova, L. A., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0839 · Cited by 112
Investigating Biological Activity Spectrum for Novel Styrylquinazoline Analogues
Jampílek, J., Musioł, R., Finster, J., Peško, M., Carroll, J., Kráľová, K., Vejsová, M., O′Mahony, J., Coffey, A., Dohnal, J., et al. (2009) · Molecules · doi:10.3390/molecules14104246 · Cited by 105
Lee, M., Lin, K., Hsiao, P., & Shin, S. (2011) · Metabolism · doi:10.1016/j.metabol.2011.06.020 · Cited by 103
Fan, Z., Shi, J., Luo, N., Ding, M., & Bao, X. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b04733 · Cited by 97
New carbazole linked 1,2,3-triazoles as highly potent non-sugar α-glucosidase inhibitors
Iqbal, S., Khan, M. A., Javaid, K., Sadiq, R., Fazal-Ur-Rehman, S., Choudhary, M. I., & Basha, F. Z. (2017) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2017.07.006 · Cited by 86
Peng, F.-W., Ji, X., Wu, T.-T., Xue, J., Ren, Z., Liu, D., Wang, X., Chen, X.-H., Zhang, J., Xu, Y., et al. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.12.033 · Cited by 83
Quinazolinone derivatives: Synthesis and comparison of inhibitory mechanisms on α-glucosidase
Wei, M.-K., Chai, W., Wang, R., Yang, Q., Deng, Z., & Peng, Y. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.09.042 · Cited by 81
Garofalo, A., Goossens, L., Six, P., Lemoine, A., Ravez, S., Farce, A., & Depreux, P. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.01.137 · Cited by 80
Chinthala, Y., Kumar, D. A., Alam, S., Singh, S. P., Arigari, N. K., Gupta, N., Srinivas, K. S., Kumar, J. K., Khan, F., Tiwari, A. K., et al. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.10.005 · Cited by 76
Peng, X.-M., Kumar, K. V., Damu, G. L. V., & Zhou, C. (2016) · Science China Chemistry · doi:10.1007/s11426-015-0351-0 · Cited by 74
Gatadi, S., Gour, J., Shukla, M., Kaul, G., Das, S., Dasgupta, A., Malasala, S., Borra, R. S., Madhavi, Y. V., Chopra, S., et al. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.08.070 · Cited by 69
Ji, Q., Yang, D., Wang, X., Chen, C., Deng, Q., Ge, Z., Yuan, L., Yang, X., & Liao, F. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.04.042 · Cited by 66
Synthesis, single crystal and antitumor activities of benzimidazole–quinazoline hybrids
Sharma, A., Luxami, V., & Paul, K. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.03.107 · Cited by 65
2-Arylquinazolin-4(3H)-ones: A new class of α-glucosidase inhibitors
Javaid, K., Saad, S. M., Rasheed, S., Moin, S. T., Syed, N., Fatima, I., Salar, U., Khan, K. M., Perveen, S., & Choudhary, M. I. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.10.038 · Cited by 63
Design, Synthesis and In Vitro Antiproliferative Activity of Novel Isatin‐Quinazoline Hybrids
Farès, M., Eldehna, W. M., Abou‐Seri, S. M., Abdel‐Aziz, H. A., Aly, M. H., & Tolba, M. F. (2015) · Archiv der Pharmazie · doi:10.1002/ardp.201400337 · Cited by 62
Peng, X.-M., Peng, L., Li, S., Avula, S. R., Kumar, K. V., Zhang, S., Tam, K. Y., & Zhou, C. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0002 · Cited by 59
Slawinski, J. J., Szafrański, K., Vullo, D., & Supuran, C. T. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.09.027 · Cited by 58
Synthesis and antitubercular activity of novel pyrazole–quinazolinone hybrid analogs
Pandit, U. P., & Dodiya, A. M. (2012) · Medicinal Chemistry Research · doi:10.1007/s00044-012-0351-0 · Cited by 56
Goss, G. D., Felip, E., Cobo, M., Lu, S., Syrigos, K., Lee, K. H., Göker, E., Georgoulias, V., Li, W., Guclu, S., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.0775 · Cited by 55
Al-Omary, F. A. M., Hassan, G. S., El‐Messery, S. M., Nagi, M. N., Habib, E. E., & El‐Subbagh, H. I. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.12.061 · Cited by 51
Yang, L., & Bao, X. (2017) · RSC Advances · doi:10.1039/c7ra04819j · Cited by 50
Peng, F.-W., Wu, T.-T., Ren, Z., Xue, J., & Shi, L. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.10.006 · Cited by 46
Design, Synthesis and Anticancer Evaluation of Novel Quinazoline-Sulfonamide Hybrids
Ghorab, M. M., Alsaid, M. S., Al-Dosari, M. S., El-Gazzar, M. G., & Parvez, M. K. (2016) · Molecules · doi:10.3390/molecules21020189 · Cited by 45
Al‐Rashood, S. T., Hassan, G. S., El‐Messery, S. M., Nagi, M. N., Habib, E. E., Al-Omary, F. A. M., & El‐Subbagh, H. I. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.07.070 · Cited by 44
Long, Q.-S., Liu, L., Zhao, Y., Wang, P., Chen, B., Li, Z., & Yang, S. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b03419 · Cited by 44
Jiang, Y., Zhang, J., Cao, Y., Chai, X., Zou, Y., Wu, Q., Zhang, D., Jiang, Y., & Sun, Q. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.06.008 · Cited by 43
Jabeen, F., Shehzadi, S. A., Fatmi, M. Q., Shaheen, S., Iqbal, L., Afza, N., Panda, S. S., & Ansari, F. L. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.12.033 · Cited by 41
Quinazoline-1-deoxynojirimycin hybrids as high active dual inhibitors of EGFR and α-glucosidase
Zhang, Y., Gao, H., Liu, R., Liu, J., Chen, L., Li, X., Zhao, L., Wang, W., & Li, B. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.08.035 · Cited by 40
Venkatesh, R., Ramaiah, M. J., Gaikwad, H. K., Janardhan, S., Bantu, R., Nagarapu, L., Sastry, G. N., Ganesh, R. A., & Bhadra, M. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.02.057 · Cited by 37
Patel, T. S., Bhatt, J. D., Dixit, R. B., Chudasama, C. J., Patel, B. D., & Dixit, B. C. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.06.038 · Cited by 37
Mphahlele, M. J., Mmonwa, M. M., Aro, A. O., McGaw, L. J., & Choong, Y. S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082232 · Cited by 36
Substituted 2-hydroxy-N-(arylalkyl)benzamides induce apoptosis in cancer cell lines
Imramovský, A., Jorda, R., Pauk, K., Řezníčková, E., Dušek, J., Hanusek, J., & Kryštof, V. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.08.009 · Cited by 31
Narita, M., Murata, T., Shimizu, K., Nakagawa, T., Sugiyama, T., Inui, M., Hiramoto, K., & Tagawa, T. (2007) · Oncology Reports · doi:10.3892/or.17.5.1133 · Cited by 29
Le-Nhat-Thuy, G., Dinh, T. V., Pham‐The, H., Quang, H. N., Thị, N. N., Thi, T. A. D., Thị, P. H., Thi, T. A. L., Nguyen, H. T., Thanh, P. N., et al. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.10.016 · Cited by 29
Maddali, N. K., Viswanath, I. V. K., Murthy, Y. L. N., Bera, R., Takhi, M., Rao, N. S., & Gudla, V. (2019) · Medicinal Chemistry Research · doi:10.1007/s00044-019-02313-9 · Cited by 24
Rational Design of Colchicine Derivatives as anti-HIV Agents via QSAR and Molecular Docking
Worachartcheewan, A., Songtawee, N., Siriwong, S., Prachayasittikul, S., Nantasenamat, C., & Prachayasittikul, V. (2018) · Medicinal Chemistry · doi:10.2174/1573406414666180924163756 · Cited by 23
Shao, J., Chen, E., Shu, K. W., Chen, W., Zhang, G., & Yu, Y. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.04.046 · Cited by 22
Patel, T. S., Bhatt, J. D., Vanparia, S. F., Patel, U. H., Dixit, R. B., Chudasama, C. J., Patel, B. D., & Dixit, B. C. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.10.041 · Cited by 21
Patel, T. S., Bhatt, J. D., Dixit, R. B., Chudasama, C. J., Patel, B. D., & Dixit, B. C. (2019) · Archiv der Pharmazie · doi:10.1002/ardp.201900099 · Cited by 19
Qu, J., Wang, Y., Xu, P., Xiang, D., Yang, R., Wei, W., & Qu, Q. (2017) · Oncotarget · doi:10.18632/oncotarget.15475 · Cited by 14
Doxazosin for the treatment of nightmare disorder: A diary-based case study
Pallesen, S., Hamre, H. S., Lang, N., & Bjorvatn, B. (2020) · SAGE Open Medical Case Reports · doi:10.1177/2050313x20936079 · Cited by 8
Metadata
- Authors
- Auti, P. S., George, G., & Paul, A. T.
- Venue
- RSC Advances
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2020
- Volume
- 10
- Issue
- 68
- Pages
- 41353-41392
- ISSN
- 2046-2069 (ISSN-L)
- OpenAlex
- W3103176295
- Cited by
- 324
- References
- 70
- FWCI
- 11.78
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.